Stanislas VEILLET – PhD – Chairman – CEO
Stanislas Veillet created Biophytis in September 2006. He previously held a number of positions in the fields of medical research, nutrition and functional foods, in particular with Danone, Pharmacia-Monsanto and Cargill. Stanislas has a doctorate in genetics, graduated in engineering from AgroParisTech and has authored a dozen patents.
Edouard Bieth – Chief Strategy Officer
Edouard Bieth spent his entire career in the pharmaceutical industry. His solid expertise in market access, sales and marketing strategy makes him a recognized leader. He held numerous senior management positions in France and abroad, and contributed to the launch of a number of blockbuster medecines at AstraZeneca, Servier and Menarini. Most recently, Edouard spent 6 years as Managing Director France & BeNeLux of Tillotts Pharma's commercial affiliate. He holds a Master's degree in biology and pharmacology of ageing, and trained in sales and marketing strategy at HEC Paris and in finance at London Business School.
Chiara Baccelli – Director of Pharmaceutical Operations and Quality Assurance
Chiara Baccelli holds more than 20 years of experience in the development and production of pharmaceutical products, especially from natural origins. After a first experience in academic research, Chiara has notably worked for UCB in Belgium, for the French group Delpharm, the company Bioprojet and also for the consulting firm IDD in France in collaboration with large pharmaceutical groups such as Boehringer Ingelheim, Ipsen or Sanofi. She has covered different roles around the development of innovative products, from CMC to Quality Assurance and Control, Industrialization and Regulatory Affairs in a worldwide environment. She holds a PharmD from the University of Pisa in Italy, a PhD in Pharmaceutical and Biomedical Sciences (extraction of active principles from plants) from the Catholic University of Leuven in Belgium and an executive MBA in Corporate Entrepreneurship & Innovation from IRIIG in Lyon.
Pierre J. DILDA – PhD – Chief Scientific Officer
PhD in Pharmacology (Paris V University), Dr. Dilda has more than 20 years of experience in pharmaceutical research, in both academic and industrial settings (Mayoli Spindler Laboratories). Before joining Biophytis in December 2015, he was Senior Research Fellow at the Lowy Cancer Research Center at the University of New South Wales (UNSW) in Sydney, Australia, where he was responsible for advancing several cancer therapeutics.
Waly DIOH – PhD – Chief Operating Officer
With a doctorate in phytopathology (Paris XI), Waly Dioh spent most of his career with R&D teams in Monsanto, initially in France to set up a genotyping platform and then in the United States (Saint Louis – Missouri) where he ran a regulatory affairs team for the development of biotechnology products. He joined Biophytis at the inception and manages current clinical trials.
Professor Jean Mariani – Chief Medical Officer
Jean Mariani is Emeritus Professor of Neuro and Gerosciences at Sorbonne Université (SU) in Paris, and was hospital practitioner at the Charles Foix geriatric hospital since 2018. His work has concerned neuromuscular aging and neurodegenerative pathologies during lifespan and expanded to general aging biology, especially the physio or pathological consequences of cellular resilience to stress. He was also in several positions of responsibility at P. and M. Curie Univ. (now SU), at the Life Sciences Department in CNRS and in other institutions, such as the Foundation for Medical Research, the DHU FAST (Fight Aging And Stress), the DIM Longevity and the Gerond’IF, etc.. Up to now Jean Mariani has published 291 papers in peer reviewed journals and has directed 34 PhD thesis. He is now President of the Scientific Council and member of the Board of the Biotech Biophytis.